Details of the Drug

General Information of Drug (ID: DMZ2VE3)

Drug Name
1,1,1-Trifluoro-6-(naphthalen-2-yl)hexan-2-one
Synonyms FKGK18; 1071001-09-6; FKGK-18; SCHEMBL3489194; CHEMBL1095003; AOB4846; ZINC49114263; NCGC00402329-01
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 280.28
Logarithm of the Partition Coefficient (xlogp) 5.5
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C16H15F3O
IUPAC Name
1,1,1-trifluoro-6-naphthalen-2-ylhexan-2-one
Canonical SMILES
C1=CC=C2C=C(C=CC2=C1)CCCCC(=O)C(F)(F)F
InChI
InChI=1S/C16H15F3O/c17-16(18,19)15(20)8-4-1-5-12-9-10-13-6-2-3-7-14(13)11-12/h2-3,6-7,9-11H,1,4-5,8H2
InChIKey
VCWWTQMRNJSJGC-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
25060069
TTD ID
D03DIV
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cytosolic phospholipase A2 (GIVA cPLA2) TTT1JVS PA24A_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2. J Med Chem. 2010 May 13;53(9):3602-10.